IMR Press / CEOG / Special Issues / reproductive_oncology

Fertility Preservation in Female Cancer Patients

Submission deadline: 31 October 2022
Special Issue Editors
  • Alessandra Andrisani, MD, PhD
    Department of Women’s and Children’s Health SDB, University of Padova, Padova, Italy
    Interests: assisted reproductive technology; obstetrics; gynecology
  • Loris Marin, MD
    Department of Women’s and Children’s Health, University of Padua, Padua, Italy
    Interests: fertility preservation; fertility preservation; oncofertility; ovarian tissue cryopreservation; ovarian tissue transplantation; breast cancer; assisted reproductive technologies; gynaecological surgery
Special Issue Information

Dear Colleagues,

Advances in the field of oncology have led to increased survival rates for girls and young women with cancer. However, chemotherapy drugs and radiotherapy are often gonadotoxic and can cause a dramatic reduction in fertility. Since the opportunity to have children is an important quality of life factor, it is recommended that patients be referred to IVF centers before starting gonadotoxic therapies. The gold standard techniques for the preservation of fertility are currently the cryopreservation of oocytes and embryos. In December 2019, ovarian tissue cryopreservation and transplantation was recognized by the American Society of Reproductive Medicine as no longer being an experimental fertility preservation technique. This technique still has some limitations in terms of the longevity of the transplanted tissue and the potential risk of reintroducing neoplastic cells. For these reasons, several other novel treatments are also being tested.

In this special issue we will highlight the current state of the art, the role of fertility preservation techniques in improving the quality of life of young women, and the ongoing controversies relating to fertility preservation. We will also address the management of young adults and children who face infertility due to gonadotoxic treatments, with the ultimate goal of improving the outcomes for these patients.

Prof. Alessandra Andrisani and Dr. Loris Marin

Guest Editors

fertility preservation
ovarian tissue cryopreservation
ovarian tissue transplantation
reproductive oncology
assisted reproductive technologies
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 1500 USD. Submitted manuscripts should be well formatted in good English.

Published Paper (3 Papers)
Back to top